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1. Introduction       
Living organisms are constantly subjected to DNA damage whether it originates from 
intrinsic physiological processes or extrinsic stressors. Of the various types of DNA damage, 
double strand breaks (DSBs) are the most dangerous since if left unrepaired they can lead to 
either cell death or genomic instability. For this reason cells have evolved an arsenal of 
signaling and repair proteins involved in DNA double strand break sensing and repair as 
well as downstream physiological responses such as apoptosis or cell cycle arrest. DSBs can 
be generated by reactive oxygen species which are produced during normal metabolism.  
DSB formation and repair also occurs during the tightly regulated physiological processes of 
gametogenesis, V(D)J recombination of T- and B-cell receptors and antibody diversification 
during class switch recombination (CSR). In addition, DSBs can be caused by external agents 
such as ionizing radiation or chemotherapeutic agents such as etoposide.  The importance of 
DSB signaling and repair is underscored by the many human diseases and syndromes 
caused by the mutation of genes coding for DNA damage response (DDR) proteins. The 
study of knockout mouse models for DDR genes has also furthered our understanding of 
the role of these proteins in DSB repair and in normal physiology. In this chapter, DSB 
signaling and repair are reviewed. In addition, an overview of the human diseases 
associated with mutations of DSB signaling and repair proteins is given. Finally, the impact 
of mouse models on our understanding of DSB signaling and repair and its physiological 
roles is discussed.   
2. Signaling at DNA double strand breaks 
2.1 Sensing the DNA double strand breaks 
When DSBs are generated they are initially recognized by either the Ku70/Ku80 
heterodimer, the Mre11-Rad50-NBS1 (MRN) complex or members of the PARP (PARP1/2) 
family of proteins (Ciccia & Elledge, 2010). The role of these protein sensors is to bind to and 
tether the DNA ends, thereby preventing further breakage as well as to recruit additional 
proteins that are required for DSB signaling and repair. The first group of proteins to be 
recruited to DSBs after initial sensing of the breaks belongs to the phosphatidylinositol-3-
kinase-like protein kinases family. These include ATM (ataxia-telangiectasia mutated), ATR 
(ATM and Rad3-related) and the catalytic subunit of DNA-PK known as DNA-PKcs. While 
ATM and DNA-PK respond only to DSBs, ATR also responds to single strand DNA breaks.  
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Ku70/80 recruits DNA-PKcs to DSBs where it promotes DNA repair by non-homologous 
end joining whereas both PARP1/2 and the MRN complex lead to the recruitment of ATM 
which promotes homologous recombination. The MRN complex is recruited to DSBs in both 
a PARP1/2 dependent and independent manner (Ciccia & Elledge, 2010). ATM is a central 
component of the cellular response to DSBs and is predicted to have several hundred 
downstream targets many of which play a role in the DNA damage response (Matsuoka et 
al, 2007). Under normal conditions ATM is in a homodimeric form. Following DNA 
damage, it becomes autophosphorylated at Ser1981 and dissociates into its monomeric form 
and binds the damaged DNA (Bakkenist & Kastan, 2003). There, it leads to the 
phosphorylation of many downstream targets involved in the DSB response. The 
phosphorylation of ATM at Ser1981 and its initial binding to DSBs depend upon the MRN 
complex. MRN consists of three different proteins Mre11, NBS1 and Rad50. Mre11 is a DNA 
nuclease that interacts with both Rad50 and NBS1 as well as with other Mre11 molecules to 
form dimers. When paired with the other components of the MRN complex, Mre11 can have 
both double strand DNA exonuclease activity and single strand DNA endonuclease activity 
(D'Amours & Jackson, 2002). In addition, Mre11 has two DNA binding sites and intrinsic 
DNA binding activity. Rad50 is a protein that bears homology to the structural maintenance 
of chromosome (SMC) family. It is an ATPase and is needed for tethering of DNA ends 
together during the process of DNA repair.  NBS1 has a fork-head-associated (FHA) domain 
and two BRCT (BRCA1-tandem repeats) domains at its N-terminus which are used to 
recognize phospho-threonine and phospho-serine residues respectively in Ser-X-Thr 
motifs. These domains allow RAD50 to interact with several DNA damage signaling 
proteins following DSB formation. NBS1 also contains a nuclear localization signal (NLS) 
that allows the translocation of the MRN complex into the nucleus following DNA 
damage (Lamarche et al, 2010). NBS1 interacts with ATM thereby leading to its 
recruitment to DSBs. There, ATM is involved in one of the very early response to the 
formation of DSBs, mainly the phosphorylation of histone variant H2AX on Ser139 to 
form γ-H2AX (Figure 1). This phosphorylation can extend over a megabase of DNA from 
the site of DSBs (Modesti & Kanaar, 2001). The formation of γ-H2AX at the sites of DSBs is 
key for the recruitment of many effector proteins to the break sites including the 
regulators of cell cycle checkpoint and DNA repair 53BP1, BRCA1 and Rad51 (Bohgaki et 
al, 2010). The accumulation of γ-H2AX and other DNA damage signaling and repair 
proteins at the sites of ionizing-radiation induced breaks leads to the formation of 
microscopically distinct foci known as IR-induced nuclear foci (IRIFs) which can be used 
experimentally to study IR-induced DNA damage signaling and repair. The ability of 
H2AX to recruit DNA damage proteins under normal physiological conditions is 
hampered by its constitutive phosphorylation at Tyr142 by William's syndrome 
transcription factor (WSTF). This phosphorylation suppresses the ability of H2AX to 
recruit downstream signaling and effectors of the DNA damage response to the breaks. 
However, following DNA damage Tyr142 residue is dephosphorylated by the EYA 
protein phosphatases (Cook et al, 2009). γ-H2AX recruits MDC1, a mediator of the DNA 
damage response that functions as an adaptor to recruit downstream effector proteins to 
the break sites. MDC1 has two BRCT domains at its C-terminus and one FHA domain at 
its N-terminus that allow it to recognize and interact with other DNA damage response 
proteins (Stewart et al, 2003). The BRCT domains of MDC1 can recognize phosphorylation 
sites and were shown to mediate MDC1 binding to γ-H2AX.   
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Fig. 1. DNA double strand break signaling 
This interaction occurs specifically between the BRCT domain of MDC1 and the Ser139 
phosphoylation site of γ-H2AX located at the C-terminus of this protein. MDC1 also 
interacts with ATM and is phosphorylated by it at its FHA domain (Goldberg et al, 2003; 
Stewart et al, 2003). Four potential consensus TQFX sites for ATM phosphorylation have 
been found and two sites, T719 and T752, were confirmed to be phosphorylated by ATM 
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(Kolas et al, 2007; Matsuoka et al, 2007). MDC1 is thought to be dispensable for the initial 
binding of ATM to the DSBs and early H2AX phosphorylation but important for ATM and 
γ-H2AX retention at the damaged DNA sites. In fact, MDC1 acts in a positive feedback loop 
with γ-H2AX and ATM to amplify the signal at the breaks (Lou et al, 2006). MDC1 was also 
found to be important for the recruitment of other DNA damage response proteins such as 
53BP1 and NBS1 to the break sites. Recent studies have provided us with greater insight 
about the mechanisms by which MDC1 leads to the recruitment of DNA damage proteins to 
the DSBs and have highlighted the role of posttranslational modifications such as 
ubiquitylation and sumoylation in the amplification of the DNA damage response.   
2.2 Role of ubiquitylation in the DNA double strand break response 
The important role ubiquitylation plays in DNA damage signaling and DNA repair has 
been recently highlighted (Bohgaki et al, 2010; Panier & Durocher, 2009). Ubiquitin is a small 
polypeptide of about 8 KDa that can be covalently attached through an isopeptide bond to 
substrate proteins. This requires the activity of three different enzymes, a ubiquitin-
activating enzyme (E1), a ubiquitin conjugating enzyme (E2) and a ubiquitin ligase (E3). The 
combination of E2 and E3 enzymes used to ubiquitylate target proteins differ from one to 
the other thereby conferring substrate specificity to the enzyme. Ubiquitin chain attachment 
can occur through several lysine residues on the ubiquitin polypeptide. The best studied 
ones are lysine 48 (K48) and lysine 63 (K63). While K48-linked ubiquitin most often leads to 
proteasomal degradation, K63-linked ubiquitylation is involved in cellular signaling 
including DSB signaling and DNA repair. Using an siRNA screen for proteins whose  
absence lead to an impairment of 53BP1 foci formation it was found that knock-down of 
MDC1 and the E3 ubiquitin ligase RNF8 (Ring Finger protein 8) strongly inhibited 53BP1 
recruitment to DSBs (Kolas et al, 2007).  RNF8 has a RING domain which is required for its 
E3 ligase activity and is located at its C-terminus and an FHA domain located at its N-
terminus. The FHA domain of RNF8 can recognize phosphorylated MDC1 thereby allowing 
binding of RNF8 to MDC1. Therefore, MDC1 phosphorylation is required for formation of 
RNF8 IRIFs. Furthermore, it was found that RNF8 partners up with the E2 ligase UBC13 to 
mediate K63-linked ubiquitylation of H2A, H2AX and H2B (Huen et al, 2007; Kolas et al, 
2007; Mailand et al, 2007). This initial ubiquitylation of chromatin components leads to the 
recruitment of another ubiquitin ligase RNF168 (Doil et al, 2009; Stewart et al, 2009). RNF168 
contains two motifs interacting with ubiquitin (MIUs) and is thought to interact with 
ubiquitylated chromatin components through its MIUs. At the DNA breaks, RNF168, in 
collaboration with the E2 ligase UBC13, adds K63-linked polybiquitin chains to H2A and 
H2AX. This ultimately results in the subsequent recruitment of other DDR proteins to the 
break sites. For example, RNF168 is required for the formation of 53BP1 IRIFs and the 
recruitment of BRCA1 to DSB site is severely reduced in the absence of this E3 ligase 
(Bohgaki et al, 2011; Doil et al, 2009; Stewart et al, 2009).  HERC2 is a recently identified 
protein that leads to binding and stabilization of the RNF8-UBC13 complex to mediate K63-
linked histone ubiquitylation (Bekker-Jensen et al, 2010). Additionally, HERC2 was also 
found to stabilize RNF168 and to promote recruitment of DSB signaling proteins including 
53BP1 and BRCA1 to the break sites. The mechanisms through which chromatin component 
ubiquitylation leads to the recruitment of 53BP1 and BRCA1 are only partially understood.  
BRCA1 interacts with the receptor-associated protein 80 (RAP80). RAP80 recruitment to 
DSBs is dependent on γ-H2AX, MDC1 and RNF8 (Kim et al, 2007; Kolas et al, 2007; Mailand 
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et al, 2007). RAP80 contains two ubiquitin interacting motifs (UIMs) which are capable of 
specifically recognizing K-63 linked polybiquitin chains (Kim et al, 2007). The interaction of 
RAP80 and BRCA1 is mediated by another protein named Abraxas (Mailand et al, 2007; 
Wang et al, 2007). The RAP80-Abraxas-BRCA1 complex is thought to bind DSB sites 
through the recognition of RNF8- and RNF168-ubiquitylated chromatin by the RAP80 UIM 
domains (Wang et al, 2007). The way 53BP1 is recruited to the break sites is less well 
understood. 53BP1 recruitment to DSBs is mediated by the binding of its two TUDOR 
domains to di-methylated histone H4 at lysine (K) 20. Histone methylation is not increased 
from its constitutive level following ionizing radiation  suggesting that changes in 
chromatin structure following DNA damage might be responsible for the uncovering of the 
methylated histones and the binding of 53BP1. It is therefore plausible that ubiquitylation of 
H2A and H2B by RNF8 and RNF168 triggers conformational changes in the chromatin that 
lead to a better accessibility of 53BP1 to the methylated histones (Mailand et al, 2007). 
However, this hypothesis still remains to be tested. The ubiquitylation of chromatin 
components leads to the rapid amplification of the DNA damage response. However, once 
the DNA is repaired, a rapid deubiquitination of histone H2A, H2B and H2AX should occur 
to return cells to their steady-state levels. This is accomplished by ubiquitin isopeptidases 
known as deubiquitinating enzymes or DUBs. Several DUBs have been described to 
negatively regulate DSB signaling. Ubiquitin-specific protease 3 (USP3) was shown to 
deubiquitylate H2A and H2B (Nicassio et al, 2007) and to negatively regulate the activity of 
RNF8 (Doil et al, 2009). BRCC36 binds to RAP80 and is in the BRCA1 complex that also 
includes Abraxas. BRCC36 along with RAP80 can antagonize the activity of RNF8-UBC13 by 
acting as a deubiquitinating enzyme for γ-H2AX. It also leads to decreased ubiquitylation 
signal at DSB sites (Shao et al, 2009). Recently, OTUB1 (OTU domain, ubiquitin aldehyde 
binding 1) was identified as an RNF168 DUB. OTUB1 does not use its catalytic activity to 
deubiquitylate RNF168 but rather acts by binding to and inhibiting UBC13, the RNF168 E2 
conjugating enzyme (Nakada et al, 2010).  
2.3 Role of SUMOylation in DNA double strand break signaling 
SUMOylation is a posttranslational modification that involves the covalent linkage of a 
small ubiquitin-like modifier (SUMO) polypeptide to a target protein (Al-Hakim et al, 2010; 
Ciccia & Elledge, 2010). The process of SUMOylation is similar to that of ubiquitylation in 
that it also requires a SUMO-specific E1 (SAE1/SAE2), an E2 conjugating enzyme (Ubc9) 
and substrate-specific E3 ligases. Three types of SUMO molecules have been identified, 
SUMO1, SUMO2 and SUMO3. SUMO2 and SUMO3 have strong homology and share the 
same function and are therefore usually referred to as SUMO2/3. Both SUMO1 and 
SUMO2/3 are recruited to DSBs and this recruitment is dependent on the presence of RNF8 
and RNF168. The E3 ligases PIAS1 and PIAS4 are needed for the accumulation of SUMO 
molecules to the break sites. PIAS1 is involved in the accumulation of SUMO2/3 but not 
SUMO1 at DSBs whereas PIAS4 is involved in the accumulation of all three SUMO moities.  
PIAS1 and PIAS4 were both found to be important for accumulation of RNF168 and 
ubiquitylated H2A at DSB sites. Furthermore, PIAS1 and PIAS4 SUMOylate BRCA1 which 
is thought to increase its ubiquitin E3 ligase activity and the ubiquitylation of H2A by 
BRCA1 which would further amplify the DNA damage signal (Morris et al, 2009). 
SUMOylation of 53BP1 by PIAS1 and PIAS4 was also demonstrated and shown to be 
required for the efficient recruitment of 53BP1 to DSBs (Galanty et al, 2009). In summary, 
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complex posttranslation modifications such as ubiquitylation, SUMOylation, 
phosphorylation and methylation, at the sites of DSBs lead to recruitment of proteins that 
are involved in DNA repair and the regulation of cell cycle checkpoints following DNA 
damage as will be discussed in the next section.  
2.4 Cellular responses following DNA double strand breaks  
Following DNA damage, cells are faced with different options. Either to undergo cell cycle 
arrest and repair the damaged DNA, to undergo senescence or to die by apoptosis.  There 
are three checkpoints put in place to arrest the cell cycle following DNA damage. The G1/S 
checkpoint, the intra-S checkpoint and the G2/M checkpoint (Warmerdam & Kanaar, 2010). 
These checkpoints are carefully regulated by ATM and its downstream effectors. ATM 
phosphorylates and activates the protein kinase Chk2 and the tumor suppressor p53 which 
then act to enforce cell cycle arrest or apoptosis. Chk2 activation requires phosphorylation 
by ATM at Thr68 and autophosphorylation at multiple other residues. Chk2 
phosphorylation of the cdc25 phosphatases which are needed for cell cycle progression lead 
to either their degradation (in the case of cdc25A) or their export from the nucleus (for 
cdc25B and cdc25C) thereby preventing interaction with their respective cdk/cyclin 
substrates (Donzelli & Draetta, 2003). Chk2 also phosphorylates p53 at Ser20 whereas ATM 
phosphorylates it at Ser15. This results in the accumulation of p53 and its activation as a 
transcription factor which transactivates many genes whose products are involved in cell 
cycle arrest such as p21, GADD45 and 14-3-3σ. p53 also transactivates several proapoptotic 
genes such as Noxa, PUMA and Bax, thus triggering apoptotic cell death of the damaged 
cells. The mechanisms that lead to p53-dependent cell cycle arrest versus p53-dependent 
apoptosis remain poorly understood but are likely to depend on the multiple 
posttranslational modifications of p53 (Vousden, 2006) .  
3. DNA repair  
Cells have evolved different pathways to repair DSBs. Currently, homologous 
recombination (HR) and non-homologous end joining (NHEJ) are recognized as the  
two major pathways for DSB repair (Kass & Jasin, 2010). The presence of undamaged sister 
chromatid is required for the error-free HR-mediated DSB repair, whereas NHEJ repair  
can occur in the absence of a homologous template sequence and is therefore considered  
to be more error-prone. Alternative NHEJ is another form of DNA repair that does  
not necessitate the presence of classical NHEJ DNA repair proteins and is characterized  
by sequence deletion and the introduction of microhomologies within the repaired  
DNA (Kotnis et al, 2009).  
3.1 Non–homologous end joining 
NHEJ is the most commonly used pathway for the repair of DSBs. Since it does not require 
the presence of a homologous sequence on a sister chromatid, it can occur throughout the 
cell cycle but particularly during G0, G1 and early S-phase (Kass & Jasin, 2010).  
The first step of NHEJ is the recognition of the DSBs by the Ku70/Ku80 heterodimer which 
consists of the Ku70 and Ku80 subunit (Figure 2). The Ku70/Ku80 complex then slides 
inwards, away from the edge of the DSBs to allow binding of two molecules of the catalytic 
subunit of DNA-PK, DNA-PKcs. When DNA-PKcs binds to DNA and Ku70/Ku80 it is 
known as DNA-PK. The two DNA-PKcs molecules bind to each other, thereby bringing 
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Fig. 2. Repair of DNA double strand breaks by non-homologous end joining 
together the DNA ends in a process called synapsis. Binding of Ku70/Ku80 and DNA-PKcs to 
the DNA ends in this manner protects them against nuclease degradation in the cell. DNA-
PKcs is a serine-threonine kinase whose activity is stimulated by binding to double stranded 
DNA and the Ku heterodimer. Phosphorylation of DNA-PKcs is needed to bring the proteins 
involved in DNA end processing such as Artemis, the DNA polymerase family members 
polymerase µ and polymerase λ, and the Polynucleotide kinase (PNK) to the break sites. End 
processing of the DNA at DSBs allows the removal of DNA lesions that interfere in the ligation 
process (Mahaney et al, 2009).  Artemis is thought to be recruited to DSBs by binding to 
autophosphorylated DNA-PKcs. While Artemis has inherent 5’→3’ exonuclease activity, in the 
presence of DNA-PK and ATP it also acquires endonuclease activity. DNA-PK promotes the 
endonucleolytic activity of Artemis versus its exonucleolytic activity and decreases the speed 
of nucleotide removal. This is important to limit the amount of trimming done at the DNA 
ends to the minimum. DNA polymerases µ and λ are brought to the DSB sites via their 
interactions with either Ku70/Ku80 or the XRCC4/DNA ligase complex. Their role at the 
DSBs involves filling in gaps to allow ligation. DNA polymerase µ is less dependent than DNA 
polymerase λ on the presence of a template.  PNK was also shown to play a role in NHEJ. It 
associates with XRCC4 and is dependent on its presence for its activity. It can phosphorylate 
5’-OH terminal groups and dephosphorylate 3’-ends to restore normal DNA ends that can be 
ligated by the XRCC4/DNA ligase complex (Chappell et al, 2002). Aprataxin and PNK–like 
factor (APLF) is an endo-exonuclease that was shown to be required for full NHEJ activity. It 
can interact with other NHEJ factors such as Ku and XRCC4 and is phosphorylated by ATM in 
a DNA damage–dependent manner (Macrae et al, 2008). XRCC4 is thought to act as a 
scaffolding protein that brings many factors involved in NHEJ to the break sites. XRCC4 and 
DNA ligase IV, along with XLF (also known as Cernunnos) form a complex known as X4-L4. 
DNA ligase activity is thought to be stimulated by its binding to XRCC4 and to XLF.  XRCC4 
and XLF can bind to Ku proteins and to DNA. The X4-L4 complex is capable of ligating one 
strand of DNA at a time which would allow for concomitant processing and ligation of the 
ends (Hartlerode & Scully, 2009).  
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3.2 Alternative non-homologous end joining 
When one or more classical NHEJ factors (Ku, DNA-PKcs, XRCC4, DNA ligase IV) are 
missing, DSBs can be repaired through the alternative NHEJ (Alt-NHEJ) pathway. This type 
of DNA repair relies on the presence of microhomologies at the terminal ends of the DNA 
breaks. It was found that Alt-NHEJ can occur in the absence of DNA ligase IV suggesting 
that one of the two remaining ligases (LigI or LigIII in eukaryotes) can function in DSB end 
ligation. End joining in the absence of LigIV requires 2-3 nucleotides of homology to 
stabilize the DNA at broken ends whereas no microhomology is needed in normal cells for 
NHEJ to occur. Furthermore it was found that a 4 nucleotide long microhomology at the 
break ends greatly decreases the requirement for Ku70, probably because of the increased 
stabilization of the DNA ends. Alt-NHEJ is stimulated by the presence of CtIP (CtBP-
interacting protein) and suppressed by the classical NHEJ factors Ku and XRCC4-LigIV 
(Bennardo et al, 2008; Simsek & Jasin, 2010). It was found that Alt-NHEJ promotes 
chromosomal translocations which might explain the increase of hematological cancer 
incidence in the absence of one or more classical NHEJ factors (Simsek & Jasin, 2010).  
3.3 Homologous recombination   
Homologous recombination requires the presence of homologous sequences for the accurate 
repair of DSBs. It usually occurs in the late S phase or G2 phase when a sister chromatid is 
available to be used as a template for repair (Ciccia & Elledge, 2010; Kass & Jasin, 2010).  The 
first step of HR is the generation of 3’- ssDNA (single stranded DNA) overhangs with 3’-
hydroxyl ends which subsequently invade a homologous duplex DNA sequence (Figure 3). 
Initial processing of the DNA ends requires the MRN complex along with CtIP. Further 
processing is done by Exo1 in association with the helicase Bloom syndrome protein BLM 
(Nimonkar et al, 2008). The 3’–ssDNA overhangs generated by this process are then be 
bound by RPA (replication protein A) which is needed to melt the secondary structures of 
the DNA and protect the DNA ends before the binding of other HR proteins can occur. RPA 
is required for the recruitment of HR factors such as the DNA-dependent ATPase Rad51 to 
the break sites (Sleeth et al, 2007).   
 
 
Fig. 3. Double strand break repair by homologous recombination  
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Rad51, a key HR player, belongs to the Rad52 epistasis group in yeast which is involved in 
recombinational DNA repair.  Rad51 competes with RPA for binding to the DNA. Since it 
has lower affinity to DNA than RPA, other factors are needed to displace RPA and lead to 
the formation of Rad51-DNA nucleofilaments. This step requires the presence of the breast 
cancer susceptibility protein 2 (BRCA2). BRCA2 binds to Rad51 through its BRC repeats and 
its carboxy-terminus. BRCA2 facilitates the binding of Rad51 to the DNA by promoting RPA 
displacement and decreasing its ability to bind double stranded DNA. In addition, it inhibits 
the ATPase activity of Rad51, thereby stabilizing the Rad51-ssDNA complexes (Jensen et al, 
2010). Once it binds to the ssDNA, Rad51 catalyzes invasion of a homologous duplex DNA 
sequence, thereby forming a displacement loop (D-loop).  This process is known as synapsis 
and requires the presence of the Rad54 motor protein. Rad54, a member of the Rad52 
epistasis group, binds to the Rad51-DNA nucleofilament, stabilizes it and therefore 
enhances D-loop formation. However, following synapsis, Rad54 promotes dissociation of 
Rad51 from double stranded DNA (dsDNA) which allows synthesis of the DNA strand. 
Rad54-mediated dissociation of Rad51 from dsDNA also allows for rapid Rad51 turnover 
(Heyer et al, 2010). After the D-loop is formed, DNA repair can occur in three distinct 
pathways: break-induced replication (BIR), synthesis-dependent strand annealing (SDSA) 
and double Holliday junctions (dHJ) (Heyer et al, 2010). BIR occurs when only one DNA 
strand is available to invade duplex DNA. This could occur during replication fork collapse 
or the uncapping of telomeres. This leads to the formation of a bona fide replication fork at 
this site. DNA synthesis at this site occurs using the regular DNA polymerases (Llorente et 
al, 2008).  During SDSA the invading strand is elongated by DNA synthesis. The D-loop is 
then reversed, allowing the newly synthesized end to anneal to the resected opposite end of 
the break. The remaining gaps in the DNA are then filled by DNA synthesis and ligation. 
SDSA results in non-crossover recombination and is the main pathway used in somatic cells 
(Sung & Klein, 2006). Finally dHJ mediated recombination involves invasion of the second 
DNA break  into the D loop, DNA synthesis and ligation to join the two invading DNA ends 
and then dHJ resolution in either a crossover or a non-crossover manner (Sung & Klein, 
2006). BLM helicase in conjunction with topoisomerase IIIa leads to the dissolution  of HJs to 
form non-crossover products. The Mus81-Eme1 endonuclease complex, SLX1-SLX4 complex 
or the human 5’-flap endonuclease GEN1 are capable of resolving dHJ to form both 
crossover and non-crossover products (Ciccia & Elledge, 2010; Hartlerode & Scully, 2009; 
Rass et al, 2010).  
3.4 Choosing between homologous recombination and non-homologous end joining  
The choice of the DNA repair pathway following DSB formation is dependent on many 
factors. One of the important determinants that allow the cells to choose whether the 
damaged DNA should be repaired by HR or NHEJ is the cell cycle phase in which it is in. 
NHEJ can occur throughout the whole cell cycle and is the pathway of choice during the G1 
phase whereas DSBs in cells in late S and G2 phases are most likely to be repaired by HR. 
DNA resection to form 3’ssDNA overhangs is a tightly regulated step because if it occurs it 
actually commits the cells to repair their DNA using HR versus NHEJ. Binding of CtIP to 
DSBs promotes resection of the break ends. CtIP levels are regulated in a cell cycle-
dependent manner and are elevated during the S, G2 and M phases of the cell cycle but are 
low during the G1 phase. In addition, CtIP activity is regulated through posttranslational 
modifications. CtIP is phosphorylated by CDK2 (cyclin dependent kinase 2) during the S 
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and G2 phases of the cell cycle at two different sites S327 and T847. Phosphorylation of CtIP 
at S327 allows it to interact with the BRCT domain of BRCA1 and with the MRN complex. 
This then results in the ubiquitylation of CtIP by BRCA1 (Yu et al, 2006). Posttranslational 
modification of CtIP by phosphorylation and ubiquitination as well as its interaction with 
BRCA1 were found to be necessary for it binding to DNA and its role in DNA resection. 
CtIP is also predicted to be a target of ATM phosphorylation and ATM is required for end 
resection.   
There are many lines of evidence showing competition between the NHEJ and HR pathways 
for DSB repair. In the absence of the NHEJ factors Ku and XRCC4-LigIV there is an increase 
in end resection and HR. Conversely, mutations in resection factors such as CtIP result in 
increased NHEJ (Kass & Jasin, 2010). Recently, 53BP1, a protein involved in cell cycle 
checkpoint and DNA repair has been implicated in the regulation of the switch between 
NHEJ and HR repair pathways.  Some studies have shown that 53BP1 is important for 
NHEJ. In addition, 53BP1 is thought to bind to the DSB sites and inhibit DNA resection. 
Loss of 53BP1 in Brca1-null cells results in increased HR activity in these cells suggesting a 
model whereby 53BP1 inhibition of end resection is overcome by BRCA1, thereby leading to 
HR-mediated DNA repair (Bouwman et al, 2010; Bunting et al, 2010) . The mechanisms by 
which BRCA1 can counteract 53BP1 function and promote HR are still unknown but 
promise to be the focus of intense research in the future.  
4. Double strand break repair in normal physiological processes 
4.1 Meotic recombination  
Meosis is a specialized type of cell division occurring during gametogenesis. It allows the 
production of haploid cells, containing one copy of the genetic material, from diploid cells 
containing two copies of the genetic material (Kumar et al, 2010). Meotic recombination is a 
crucial process during gametogenesis. It occurs during the prophase of the first meiotic 
division (prophase I) and allows the formation of physical links called chiasmata between 
two homologous chromosomes. This ensures proper alignment and segregation of the 
homologous chromosomes during the later phases of meiosis I. DNA recombination during 
meiosis also allows the exchange of genetic material between homologous chromosomes. 
This is required to ensure genetic diversity of the organisms and for introduction of 
mutations needed for the evolution of species. Meiotic recombination requires a highly 
regulated generation of DSBs followed by their repair through HR. The first step of meiotic 
recombination is the generation of DSBs during the leptotene stage of prophase I. This stage 
occurs directly following S phase when DNA replication has occurred. Spo11, a highly 
conserved type II-like topoisomerase, generates the DSBs needed to initiate meiotic 
recombination through a transesterification reaction (Keeney et al, 1997). Spo11 binds to 
both strands of the DNA as a homodimer. Once the DSB is generated, the DNA on which 
Spo11 is attached is cleaved, thereby releasing a Spo11-oligonucleotide complex. In addition 
to Spo11, several other proteins were identified as been involved in DSB formation although 
their mechanism of action is still poorly understood. One of them, Mei4 (MEIosis-specific 4), 
is needed for DSB formation in both yeast and mammals (Kumar et al., 2010). Mei4 binds to 
another protein, Rec114 (RECombination 114) which is also essential for DSB formation in 
yeast. Although the role of Rec114 in mammals is still unknown, its interaction with  
Mei4 makes it plausible that they function together in DSB generation in mammals (Kumar 
et al, 2010).  
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DSBs do not occur evenly throughout the genome but arise more frequently in specific areas 
called ”hotspots”.  In yeast and mouse it was found that these hotspots are marked by the 
trimethylation of histone 3 at Lys4 (H3K4Me3) (Borde et al, 2009). Recently, a histone 
methyltransferase, PRDM9 (PR domain containing 9), was identified as a protein that can 
bind to and activate hotspots in mammalian genomes (Baudat et al, 2010). After end 
processing to form 3’-ssDNA, the resected DNA is bound by Rad51 and Dmc1 (Disrupted 
meiotic cDNA1), a meiosis-specific recombinase. In the yeast Saccharomyces cerevisiae, 
recruitment of Dmc1 to resected DNA ends is dependent upon the two proteins Mei5 and 
Sae3. Mei5 and Sae3 (Sporulation in the Absence of Spo Eleven 3) form a complex that 
allows Dmc1 binding to the single stranded DNA and enhances its recombinase activity 
(Ferrari et al, 2009). The resected ends can then invade double stranded DNA and form a D-
loop. Two proteins, Hop2 and Mnd1 which exist in cells as a heterodimeric complex help in 
the stabilization of the Rad51 and Dmc1 nucleofilaments and increase their ability to invade 
homologous duplex DNA. Hop2 and Mnd1 function both in yeast and higher eukaryotes, 
including mammals (Petukhova et al, 2005; Tsubouchi & Roeder, 2002). In contrast to HR 
occurring in somatic cells which use sister chromatids as a template, the use of a non-sister 
homologous chromatid is favored during meiotic recombination (Shinohara et al, 1992). The 
Holliday junctions that form following strand invasion are then resolved to form crossover 
and non-crossover products. In contrast to what happens during HR in somatic cells, 
meiotic recombination generates a much higher proportion of crossover products as 
compared to non-crossover products (Andersen & Sekelsky, 2010). In both S. cerevisiae and 
higher eukaryotes the Msh4-Msh5 (MutS homolog 4-5) complex plays an important role in 
the resolution of HJs and in crossover formation. It was also suggested that GEN1 could 
play a role in HJ resolution during human meiotic recombination (Lorenz et al, 2009), 
however further investigation is needed to prove this hypothesis.  
4.2 V(D)J recombination  
V(D)J recombination is a crucial process in lymphocyte development through which diverse 
B and T cell receptors can be generated (Soulas-Sprauel et al, 2007). It involves the assembly 
of a variable (V), diversity (D) and joining (J) exons to form a B cell or T cell antigen 
receptor. The multiple combinations that can be obtained by joining together different V, D 
and J segments are the underlying mechanism for antigen receptor diversity and the ability 
of the immune system to respond to different types of pathogens. RAG1 and RAG2 
(recombination activating genes 1 and 2) are two lymphocyte-specific recombinases that 
introduce DSBs at specific recombination signal (RS) sequences that border every V, D and J 
gene segment (Dudley et al, 2005). RS sequences consist of a conserved heptamer and a 
conserved nonamer separated by a nonconserved 12 bp or 23 bp spacer sequence. In the 
heavy chain immunoglobulin gene (IgH) for example, RS sequences that surround D 
sequences have a 12 bp spacer whereas those surrounding the V and J segments have 23 bp. 
Since recombination can occur only between RS sequences containing a 12 bp spacer and 
one containing a 23 bp spacer this ensures productive joining of V, D and J sequences 
(Dudley et al, 2005). RAG mediated cutting of the DNA generates hairpin loops at the 
joining DNA ends. These hairpin loops are cleaved by the endonuclease Artemis which is 
recruited and activated by the DNA-PKcs and Ku70/80 complex. The XRCC4/DNAligase 
IV/XLF complex  then religates the joining ends (Soulas-Sprauel et al, 2007).  
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4.3 Class switch recombination  
Class switch recombination (CSR) is a specialized mechanism occurring in B cells that 
allows the cells to switch from expressing immunoglobulin (Ig) M (IgM) to IgG, IgA or IgE 
(Stavnezer et al, 2008).  This involves replacement of the IgH constant region Cµ encoded in 
IgM with more downstream constant regions such as Cγ, Cε and Cα which code for IgG, IgE 
and IgA heavy chain constant regions respectively. This replacement of IgH constant 
regions is mediated through deletion of parts of the chromosome and subsequent 
recombination. CSR occurs within or nearby specific sequences called the switch regions 
that precede every constant region. CSR is initiated upon antigenic stimulation of mature B 
cells and requires at least two rounds of cell division  and the presence of a B cell-specific 
enzyme activation induced cytidine deaminase (AID) that converts deoxycytosine (dC) to 
deoxyuracil (dU) in the donor and receiver S regions (Muramatsu et al, 2000). The dU is then 
removed through the base excision repair pathway. The enzyme that cleaves dU in S regions 
is the uracil DNA glycosylase UNG. The phosphate backbone of the resulting abasic site is 
then cleaved by the apurinic/apyrimidinic endonucleases APE1 and APE2, two proteins 
which were found to be essential for CSR, to form a single strand DNA break (Guikema et 
al, 2007). In order for CSR to occur, DSBs must be created in the donor and acceptor S 
regions and the single stranded breaks generated by APE1 and 2 are not enough. When 
single stranded breaks are generated close enough to each other they might lead to the 
formation of DSBs. Otherwise, DSBs must be generated by mismatch repair (MMR) proteins. 
It is hypothesized that the MMR heterodimer Msh2-Msh6 (MutS homolog 2-6) recognizes 
the mismatched U:G pair and binds to it. Mlh1-Pms2 (MutL homolog 1-PostMeiotic 
Segregation 2) then binds to Msh2-Msh6 to form a heterotetramer capable of recruiting the 
exonuclease Exo1. Exo1 cuts the DNA between two single stranded breaks thereby resulting 
in a DSB (Stavnezer et al, 2008).  
DSBs in the S regions are religated using the NHEJ repair machinery. However NHEJ 
factors are not the only proteins involved in CSR.  Studies of mouse knockout models have 
implicated Atm, Mdc-1, γ-H2ax and 53bp1 in the CSR process (Kotnis et al, 2009). More 
recently, the E3 ligases Rnf8 and Rnf168 have also been implicated in the process of CSR 
(Bohgaki et al, 2011; Li et al, 2010; Santos et al, 2010; Stewart et al, 2007). Interestingly, in B 
cells of mice that are deficient in classical NHEJ repair proteins, sequencing of switch 
junctions have shown a pattern of increased microhomology suggesting that CSR could be 
occurring through alternative NHEJ pathways in these cells (Kotnis et al, 2009). Of all of the 
DSB repair proteins, loss of 53bp1 seems to have the most severe effect on CSR with a 90% 
decrease in CSR in 53bp1-null B cells (Kotnis et al, 2009). There have been several roles 
proposed for 53BP1 in CSR. One of them is that that 53BP1 inhibits intraswitch religation of 
DSBs and promotes synapsis between DSBs occurring in distal switch sequences. In 
addition, 53BP1 inhibits DSB resection which is needed for alternative NHEJ, thereby 
leading to increased DSB repair through the classical NHEJ pathway and to increased CSR 
(Bothmer et al, 2010). Despite many advances in the field of CSR and in the function of 
factors required for this process, further investigation is still required to determine the 
precise role of each DSB repair protein in CSR.  
5. DSB signaling and repair defects: Human diseases and mouse models  
The study of rare hereditary diseases and knockout mouse models in which DSB signaling 
and repair genes are mutated has greatly increased our understanding of the DNA damage 
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signaling and repair pathways and the underlying mechanisms regulating them (Bohgaki et 
al, 2010; Hakem, 2008). In this section, a summary of the human syndromes and mouse 
phenotypes associated with the loss of the major DSB signaling and repair proteins is 
provided.   
5.1 ATM  
Mutations in the ATM gene result in the devastating disease ataxia-telangiectasia (A-T). A-T 
is an autosomal recessive disorder. Clinical symptoms of A-T include cerebellar ataxia, 
oculocutaneous telangiectasias, immunodeficiency, growth retardation, lack of gonadal 
development, insulin resistance and increased susceptibility to lymphoid cancers (Lavin, 
2008). The ataxia manifests itself at an early age when the child starts to walk and worsens 
with time as the patients usually becomes wheel-chair bound by the end of the first decade 
of their life. Ataxia in A-T patients is caused by degeneration of Purkinje and granular cells 
in the cerebellum. A-T patients are immunodeficient, have reduced thymus size and lower 
serum levels of IgG, IgA and IgE. One of the striking features of A-T is a severe sensitivity to 
ionizing radiation. This has been observed in both A-T patients who were undergoing 
radiotherapy and in A-T cells grown in culture. Some patients with A-T develop insulin 
resistance and diabetes. Although this particular symptom was initially hard to explain 
through the DNA damage signaling functions of ATM, it has recently become clear that 
ATM is also a key player in insulin signaling and that it can protect against metabolic 
disorders (Halaby et al, 2008; Matsuoka et al, 2007).  About one third of A-T patients 
develop lymphoid malignancies.   
The phenotype of Atm-deficient mice closely resembles what has been observed in A-T 
patients. The mice are growth-deficient, sterile, immunodeficient and display increased 
radiosensitivity. In addition, most mice succumb to thymic lymphoma by 6 months of age 
(Barlow et al, 1996). Furthermore, it has been reported that Atm-/- mice have CSR defects 
(Kotnis et al, 2009). Interestingly, Atm-/- mice do not recapitulate entirely the severe 
neurodegeneration observed in A-T patients. Mild ataxia has been reported in Atm-/- mice, 
however there were no signs of degeneration in the cerebellum such as those observed in A-T 
patients (Barlow et al, 1996). This suggests that although ATM functions are mostly conserved 
from mice to humans, it might not be the case in neuronal cells of these organisms.  
5.2 The MRN complex  
5.2.1 MRE11 
Hypomorphic mutations in the human MRE11 gene lead to A-T like disorder (ATLD). 
ATLD is a very rare disorder that shares many similarities with A-T disease (Stewart et al, 
1999).  ATLD patients display progressive cerebellar ataxia and their cells are radiosensitive. 
However, in contrast with A-T patients, ATLD patients display normal Ig levels, lack of 
telangiectasia occurrence and they do not have increased susceptibility for cancer 
development (Taylor et al, 2004).   
Straight knockout mice for Mre11 are embryonic lethal, suggesting that Mre11 is necessary 
for embryonic development (Xiao & Weaver, 1997). An ATLD mouse model was developed 
in which a hypomorphic Mre11 is expressed (Mre11ATLD1/ATLD1 mice). These mice appear to 
have normal growth; however mouse embryonic fibroblasts derived from these mice have 
increased radiosensitivity, blunted intra-S and G2/M checkpoints and higher levels of 
genomic instability (Theunissen et al, 2003). However, Mre11ATLD1/ATLD1 mice did not develop 
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lymphomas. Interestingly, female Mre11ATLD1/ATLD1 mice have a severely reduced fertility due 
to an inability of developing embryos to proliferate properly.  
5.2.2 NBS1 
NBS1 hypomorphic mutations are the underlying cause for the Nijmegen Breakage 
syndrome (NBS) (Carney et al, 1998). NBS patients display stunted growth, microencephaly, 
immunodeficiency, increased radiosensitivity and increased cancer incidence (Digweed & 
Sperling, 2004). NBS patients have decreased IgA and IgG level which shows that NBS1 
plays an important in CSR (van Engelen et al, 2001). Some female patients also showed 
ovarian failure and amenorrhea. Lymphomas are the most common malignancies observed 
in NBS patients although other cancers such as medulloblastomas were also diagnosed in 
these patients (Digweed & Sperling, 2004).  
As with Mre11, straight knockout mice of Nbs1 are not viable (Zhu et al, 2001). Mice with 
conditional deletion of Nbs1 in B cells had increased genomic instability in B cells and CSR 
defects (Reina-San-Martin et al, 2005). However and interestingly so, mice with 
hypomorphic mutation of Nbs1 that mimics a mutation observed in NBS1 patients display a 
generally milder phenotype than what is observed in NBS patients (Williams et al, 2002). 
Mouse embryonic fibroblasts derived from these mice show increased sensitivity to DNA 
damaging compounds, defects in cell cycle checkpoints and increased chromosomal 
instability. However, these mice with homozygous Nbs1 hypomorph mutation do not show 
immunodeficiency, increased susceptibility to tumor development or female sterility.  
5.2.3 RAD50  
Recently, a human disorder caused by mutations in the RAD50 gene was characterized 
(Waltes et al, 2009). This disorder was described as being NBS-like since the only known 
patient with this disorder shares similar features with NBS patients. Clinical features of the 
RAD50 (NBS-like) disorder patient include microencephaly, growth retardation and slight 
ataxia. The patient has a normal immune system and did not develop any tumors by the age 
of 23. Cells derived from the patient displayed radiosensitivity, G1/S and G2/M checkpoint 
defects, radioresistant DNA synthesis and increased genomic instability.  
Rad50-null mutant mice are not viable and die early during embryonic development. Viable 
Rad50 hypomorphic mice were generated (Bender et al, 2002). These mice have strong 
growth defects and most die from anemia caused by hematopoietic stem cell failure.  
Mutant mice that survive develop lymphomas and leukemia and males exhibit degeneration 
in the testes. Mouse embryonic fibroblasts with the Rad50 hypomorphic mutation are not 
sensitive to radiation or DNA damaging agents and do not perform radioresistant DNA 
synthesis.  
5.3 RNF168 
RNF168 was recently identified as the gene mutated in the RIDDLE (radiosensitivity, 
immunodeficiency, dysmorphic features and learning difficulties) syndrome (Stewart et al, 
2009; Stewart et al, 2007). The RIDDLE syndrome was identified in only one patient to date 
and is characterized by immunodeficiency with decreased IgG levels but slightly increased 
IgA and IgM levels. The RIDDLE patient also displayed a mild decrease in motor and 
learning abilities, shorter stature and facial dysmorphism. Fibroblasts derived from the 
RIDDLE patient showed increased radiosensitivity.  Interestingly, another patient with 
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RNF168 gene mutation was recently identified (Devgan et al, 2011). This patient also 
displayed short stature, cellular radiosensitivity and low serum IgA. In addition, this patient 
was reported to also display A-T like symptoms including ataxia, ocular telangiectasias, 
microencephaly, and immunodeficiency with very low IgA levels. Both patients with 
RNF168 deficiency did not develop tumors.  
Rnf168 null mice were recently generated (Bohgaki et al, 2011). These mice display normal 
growth and development and do not develop malignancies. They do however exhibit 
immunodeficiency mainly characterized by defects in CSR. Cells deficient for Rnf168 
display increased radiosensitivity and genomic instability and elevated cancer risk was 
observed in mice lacking both Rnf168 and p53.  
5.4 RNF8 
Human syndromes caused by mutations of the RNF8 gene have yet to be identified. 
However, Rnf8 mouse knockout models have been generated and have produced 
interesting phenotypes that are worth discussing here.  Rnf8-/- mice are viable and are born 
in normal mendelian ratio (Li et al, 2010; Santos et al, 2010). They have growth defects, male 
sterility, increased radiosensitivity and immunodeficiency. Rnf8-/- mice display reduced CSR 
and increased genomic instability. A broad spectrum of tumors including lymphomas, 
sarcomas and breast tumors developed in Rnf8-/- mice (Li et al, 2010). It would be interesting 
to determine whether mutations of RNF8 gene lead to human genetic disorders or if RNF8 
loss correlates with cancer development in humans.  
5.5 BRCA1 and BRCA2 
BRCA1 and BRCA2 are two breast and ovarian cancer susceptibility genes (O'Donovan & 
Livingston, 2010). Germline mutation of one BRCA1 allele results in an up to 80% cumulative 
risk of breast cancer and a 30-40% risk of ovarian cancer by 70 years of age. Carriers of a 
BRCA2 mutation have a 50% cumulative risk of breast cancer and a 10-15% risk of developing 
ovarian cancer by age 70. In addition, germline BRCA2 mutations have been implicated in 
familial prostate cancer (McKinnon & Caldecott, 2007). Tumors in BRCA1 or BRCA2 mutation 
carriers most often lose the second BRCA1 or BRCA2 allele through loss of heterozygocity. 
Recently, it has been discovered that BRCA1 and BRCA2-negative tumors are very sensitive to 
a class of compounds known as PARP inhibitors. PARP inhibitors leave unrepaired single 
strand breaks in the DNA. If these unrepaired breaks meet a replication fork either fork 
collapse or DSBs. In the absence of BRCA1 and BRCA2 DSBs are left unrepaired, thereby 
leading to cell death. In this way PARP inhibitors are able to specifically target and kill BRCA1 
and BRCA2-null cells, making these inhibitors powerful therapeutic candidates for BRCA1 and 
BRCA2 negative breast and ovarian tumors. This treatment strategy might also work for 
tumors with somatic inactivation of BRCA1 and BRCA2 (Carden et al, 2010).   
Brca1 and Brca2 knockout mice are embryonic lethal, reflecting the essential requirement for 
these two proteins (Hakem et al, 1996; Suzuki et al, 1997). Brca1-deficient cells displayed 
radiosensitivity and increased chromosomal abnormalities (Mak et al, 2000; McPherson et al, 
2004). Females carrying Brca1 targeted mutations in mammary tissue exhibit a long latency 
time before development of mammary tumors, however this latency time is reduced 
considerably in the absence of tumor suppressor proteins such as p53 and Chk2 (McPherson 
et al, 2004; Xu et al, 1999). Interestingly, it was recently shown that loss of 53bp1 in Brca1-
null mammary epithelium prevented mammary tumor development (Bunting et al, 2010), 
suggesting that 53bp1 could eventually be targeted to treated Brca1-deficient breast cancer.  
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Similar to what was observed with Brca1 conditional mutant mice, loss of Brca2 expression  
in mouse mammary epithelium leads to increased incidence of mammary tumors, the 
latency of which is shortened in the absence of a p53 allele (Jonkers et al, 2001).  Recently, 
study of a conditional knockout of Brca2 in mouse prostate epithelium showed that loss of 
Brca2 leads to increased prostate cancer incidence which is accelerated in the absence of p53 
(Francis et al, 2010).  
5.6 DNA ligase IV 
Hypomorphic mutations in the DNA ligase IV gene in humans give rise to the ligase IV 
(Lig4) syndrome. Lig4 syndrome is an autosomal recessive disorder characterized by 
microencephaly, growth retardation, mental retardation, decreased red and white blood cell 
count, immunodeficiency and increased cancer susceptibility (O'Driscoll et al, 2001). Cells 
from Lig4 patients display increased radiosensitivity and are defective in NHEJ DSB repair, 
but they have normal cell cycle checkpoints (O'Driscoll et al, 2001).   
Knocking out DNA ligase IV in mice results in late embryonic lethality with massive 
neuronal apoptosis and lymphocyte development arrest due to lack of V(D)J recombination 
(Frank et al, 1998). Mice with hypomorphic mutation of DNA ligase IV were obtained 
through a mutagenesis screen. These mice have growth defects, are immunodeficient and 
have hematopoietic stem cell exhaustion with age (Nijnik et al, 2007). 
5.7 Artemis  
Artemis is the gene mutated in radiosensitive-severe combined immunodeficiency (RS-SCID) 
(Moshous et al, 2001). RS-SCID is characterized by normal development but increased 
radiosensitivity and a complete absence of mature B and T cells that can be attributable to 
defects in V(D)J recombination. While null mutations of Artemis give rise to RD-SCID, 
hypomorphic mutations lead to a plethora of less severe immunodeficiency syndromes that 
are characterized by increased incidence of Esptein-Barr virus-induced lymphomas 
(Moshous et al, 2003).  
Artemis knockout mice are viable and display normal growth. B cell development in these 
mice is arrested at early progenitor stages. In contrast to what is observed in humans some T 
cells are able to undergo V(D)J recombination and mature normally leading to a “leaky” 
SCID phenotype (Rooney et al, 2002). Artemis-deficient cells display increased 
radiosensitivity and genomic instability. Recently, Artemis-null mice were generated in a 
different genetic background (Xiao et al, 2009). These mice exhibit complete arrest of B and T 
lymphocyte development and do not present a leaky phenotype and thus recapitulate more 
closely RS-SCID symptoms.  
5.8 DNA-PKcs  
The first DNA-PKcs human gene mutation was recently identified in a patient presenting 
classical symptoms of RS-SCID (van der Burg et al, 2009). This patient did not have mature 
B or T cells but had normal natural killer cell numbers. Cells from the patient were unable to 
properly repair DNA double strand breaks and were deficient in NHEJ. 
DNA-PKcs was initially identified as the gene inactivated in the classical scid mice. Later on, 
knockout mice for DNA-PKcs recapitulated the phenotypes of the scid mice (Gao et al, 1998). 
DNA-PKcs-/- mice exhibited no growth defects but they displayed arrested B and T cell 
development at early progenitor stages, impaired V(D)J recombination and increased 
cellular radiosensitivity.  
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5.9 NHEJ1  
NHEJ1 (Cernunnos-XLF) gene mutations were identified in patients with immunodeficiency 
and microencephaly (Buck et al, 2006). These patients are characterized by bird-like features, 
microencephaly, progressive loss of B and T cells and growth retardation. They have low 
levels of circulating IgA and IgG. Cells derived from these patients are radiosensitive but 
display normal cell cycle checkpoint.  
A mouse model in which Nhej1 is deleted has been generated (Li et al, 2008). These mice 
display a much milder phenotype than what is seen in humans. Nhej1-null mice are viable, 
born at the mendelian ratio and have normal growth and development. Although B and T 
cell numbers are reduced in Nhej1-deficient mice, a normal development of immune cells is 
observed and V(D)J recombination was not impaired in Nhej1-null lymphocytes. On the 
other hand, B cells from Nhej1-deficient mice had defective CSR. Concomitant loss of Nhej1 
and p53 resulted in the rapid occurrence of thymic lymphomas and medulloblastomas.  
5.10 Ku70 and Ku80 
Mutations in Ku70 or Ku80 genes have not yet been described in humans. However 
knockout mice have been generated for these two proteins. Similar to what has been 
observed for knockout mice of other NHEJ factors described above, Ku70 and Ku80 
deficient mice display immunodeficiency with arrested B and T cell development and 
defective V(D)J recombination (Gu et al, 1997; Nussenzweig et al, 1996). Interestingly 
though, Ku70-/- and Ku80-/- mice displayed significant growth defects and reduced size 
compared to wild-type mice. 
6. Conclusion 
DNA double strand breaks are constantly generated in our cells either through external 
stressors such as radiation or through internal programmed events that are needed for 
normal physiological processes such as gametogenesis, V(D)J recombination and class 
switch recombination. The importance of quickly detecting and repairing these breaks is 
underscored by the plethora of human syndromes caused by mutation of genes coding for 
DSB signaling and repair proteins. These syndromes share many similarities which include 
neurological defects, growth defects, immunodeficiency, radiosensitivity, sterility and 
increased cancer incidence. Although many of these symptoms have been recapitulated in 
knockout mouse models of DSB response proteins, some discrepancies between human 
syndromes and mouse models are sometimes observed which highlight differential role or 
redundancy between DSB response proteins in humans and mice. Nevertheless, study of 
these models have provided great insight into the physiological functions of DSB response 
proteins and have led to rapid discoveries in this field. Finally, these studies resulted in a 
better understanding of the etiology of certain diseases such as cancer and provided 
potential new ways of treating these diseases.  
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